Published in J Steroid Biochem Mol Biol on January 15, 2015
Adaptation to Lactose in Lactase Non Persistent People: Effects on Intolerance and the Relationship between Dairy Food Consumption and Evalution of Diseases. Nutrients (2015) 0.79
Vitamin D and the Epithelial to Mesenchymal Transition. Stem Cells Int (2016) 0.78
Vitamin D and colorectal cancer: molecular, epidemiological and clinical evidence. Br J Nutr (2016) 0.78
Cancer statistics, 2012. CA Cancer J Clin (2012) 87.38
Vitamin D deficiency. N Engl J Med (2007) 59.34
Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer. JAMA (1998) 21.31
A randomized trial of aspirin to prevent colorectal adenomas. N Engl J Med (2003) 9.18
Calcium plus vitamin D supplementation and the risk of colorectal cancer. N Engl J Med (2006) 8.73
Celecoxib for the prevention of sporadic colorectal adenomas. N Engl J Med (2006) 7.62
The effect of celecoxib, a cyclooxygenase-2 inhibitor, in familial adenomatous polyposis. N Engl J Med (2000) 7.54
Circulating 25-hydroxyvitamin D levels indicative of vitamin D sufficiency: implications for establishing a new effective dietary intake recommendation for vitamin D. J Nutr (2005) 6.32
Celecoxib for the prevention of colorectal adenomatous polyps. N Engl J Med (2006) 6.15
Treatment of colonic and rectal adenomas with sulindac in familial adenomatous polyposis. N Engl J Med (1993) 6.13
Redefining oxidative stress. Antioxid Redox Signal (2006) 4.71
Oxygen radicals and human disease. Ann Intern Med (1987) 4.57
Colorectal cancer: molecules and populations. J Natl Cancer Inst (1999) 4.39
Radical-free biology of oxidative stress. Am J Physiol Cell Physiol (2008) 4.33
Calcium supplements for the prevention of colorectal adenomas. Calcium Polyp Prevention Study Group. N Engl J Med (1999) 4.11
Vitamin D, calcium supplementation, and colorectal adenomas: results of a randomized trial. J Natl Cancer Inst (2003) 3.44
A randomized trial of rofecoxib for the chemoprevention of colorectal adenomas. Gastroenterology (2006) 3.35
Paleolithic nutrition. A consideration of its nature and current implications. N Engl J Med (1985) 3.29
Calcium and fibre supplementation in prevention of colorectal adenoma recurrence: a randomised intervention trial. European Cancer Prevention Organisation Study Group. Lancet (2000) 3.26
Endogenous oxidative DNA damage, aging, and cancer. Free Radic Res Commun (1989) 2.79
Inhibition of apoptosis during development of colorectal cancer. Cancer Res (1995) 2.77
Colon cancer: a review of the epidemiology. Epidemiol Rev (1993) 2.65
Calcium intake and risk of colon cancer in women and men. J Natl Cancer Inst (2002) 2.59
Dairy foods, calcium, and colorectal cancer: a pooled analysis of 10 cohort studies. J Natl Cancer Inst (2004) 2.54
The Vitamin D requirement in health and disease. J Steroid Biochem Mol Biol (2005) 2.47
Sulindac causes regression of rectal polyps in familial adenomatous polyposis. Gastroenterology (1991) 2.43
Effect of sulindac on sporadic colonic polyps. Gastroenterology (1995) 2.27
Cyclooxygenase-2 inhibitors in tumorigenesis (part I). J Natl Cancer Inst (1998) 2.26
Cyclooxygenase-2 inhibitors in tumorigenesis (Part II). J Natl Cancer Inst (1998) 2.09
Differential expression of bcl-2 in intestinal epithelia. Correlation with attenuation of apoptosis in colonic crypts and the incidence of colonic neoplasia. J Cell Sci (1995) 2.01
TGF-alpha expression as a potential biomarker of risk within the normal-appearing colorectal mucosa of patients with and without incident sporadic adenoma. Cancer Epidemiol Biomarkers Prev (2009) 1.98
Paleolithic nutrition revisited: a twelve-year retrospective on its nature and implications. Eur J Clin Nutr (1997) 1.88
Overexpression of transforming growth factor beta1 in head and neck epithelia results in inflammation, angiogenesis, and epithelial hyperproliferation. Cancer Res (2004) 1.71
Colorectal cancer and nonsteroidal anti-inflammatory drugs. Adv Pharmacol (1997) 1.63
Aberrant crypt foci: A review. Toxicol Pathol (2000) 1.63
Circulating levels of vitamin D and colon and rectal cancer: the Physicians' Health Study and a meta-analysis of prospective studies. Cancer Prev Res (Phila) (2011) 1.62
Possible mechanisms relating diet and risk of colon cancer. Cancer Epidemiol Biomarkers Prev (2000) 1.60
Effects of vitamin D and calcium supplementation on markers of apoptosis in normal colon mucosa: a randomized, double-blind, placebo-controlled clinical trial. Cancer Prev Res (Phila) (2009) 1.59
Relation of calcium, vitamin D, and dairy food intake to incidence of colon cancer among older women. The Iowa Women's Health Study. Am J Epidemiol (1993) 1.57
Role of supplemental calcium in the recurrence of colorectal adenomas: a metaanalysis of randomized controlled trials. Am J Gastroenterol (2005) 1.55
Carcinogen-mediated oxidant formation and oxidative DNA damage. Pharmacol Ther (1992) 1.54
Vitamin D and prevention of colorectal adenoma: a meta-analysis. Cancer Epidemiol Biomarkers Prev (2008) 1.51
Calcium and colorectal epithelial cell proliferation in sporadic adenoma patients: a randomized, double-blinded, placebo-controlled clinical trial. J Natl Cancer Inst (1995) 1.46
Endogenous DNA damage as related to cancer and aging. Mutat Res (1989) 1.41
Calcium, vitamin D, sunshine exposure, dairy products and colon cancer risk (United States). Cancer Causes Control (2000) 1.38
Smad-binding defective mutant of transforming growth factor beta type I receptor enhances tumorigenesis but suppresses metastasis of breast cancer cell lines. Cancer Res (2004) 1.38
The bcl-2 proto-oncogene and the gastrointestinal epithelial tumor progression model. Am J Pathol (1995) 1.37
BCL-2 expression in human colorectal adenomas and carcinomas. Oncogene (1994) 1.34
Identification of BMP and activin membrane-bound inhibitor (BAMBI), an inhibitor of transforming growth factor-beta signaling, as a target of the beta-catenin pathway in colorectal tumor cells. J Biol Chem (2003) 1.31
The paradoxical nature of hunter-gatherer diets: meat-based, yet non-atherogenic. Eur J Clin Nutr (2002) 1.26
Effects of supplemental vitamin D and calcium on oxidative DNA damage marker in normal colorectal mucosa: a randomized clinical trial. Cancer Epidemiol Biomarkers Prev (2010) 1.26
Mutagenesis and carcinogenesis: endogenous and exogenous factors. Environ Mol Mutagen (1989) 1.23
bcl-2 oncoprotein in colorectal hyperplastic polyps, adenomas, and adenocarcinomas. Hum Pathol (1995) 1.21
Dietary calcium and vitamin D modulate 1,2-dimethylhydrazine-induced colonic carcinogenesis in the rat. Cancer Res (1991) 1.18
Influence of dietary calcium and vitamin D on colon epithelial cell proliferation and 1,2-dimethylhydrazine-induced colon carcinogenesis in rats fed high fat diets. J Nutr (1993) 1.14
Colonic vitamin D metabolism: implications for the pathogenesis of inflammatory bowel disease and colorectal cancer. Mol Cell Endocrinol (2011) 1.14
Effects of supplemental vitamin D and calcium on biomarkers of inflammation in colorectal adenoma patients: a randomized, controlled clinical trial. Cancer Prev Res (Phila) (2011) 1.13
Inhibition of dietary fat-promoted colon carcinogenesis in rats by supplemental calcium or vitamin D3. Carcinogenesis (1988) 1.12
Effects of vitamin d and calcium on proliferation and differentiation in normal colon mucosa: a randomized clinical trial. Cancer Epidemiol Biomarkers Prev (2009) 1.12
Smad3 regulates senescence and malignant conversion in a mouse multistage skin carcinogenesis model. Cancer Res (2003) 1.11
Is Ki-67 a better proliferative marker in the colon than proliferating cell nuclear antigen? Cancer Epidemiol Biomarkers Prev (1997) 1.10
Contextual effects of transforming growth factor beta on the tumorigenicity of human colon carcinoma cells. Cancer Res (1999) 1.06
Blood 25-hydroxyvitamin D3 concentrations and incident sporadic colorectal adenoma risk: a pooled case-control study. Am J Epidemiol (2010) 1.04
A prospective cohort study of intake of calcium, vitamin D, and other micronutrients in relation to incidence of rectal cancer among postmenopausal women. Cancer Epidemiol Biomarkers Prev (1998) 1.03
Comparison of MIB-1 (Ki-67) antigen and bromodeoxyuridine proliferation indices in meningiomas. Hum Pathol (1996) 0.97
Paleolithic vs. modern diets--selected pathophysiological implications. Eur J Nutr (2000) 0.96
A randomized clinical trial of the effects of supplemental calcium and vitamin D3 on markers of their metabolism in normal mucosa of colorectal adenoma patients. Cancer Res (2010) 0.96
Calcium nutrition and extracellular calcium sensing: relevance for the pathogenesis of osteoporosis, cancer and cardiovascular diseases. Nutrients (2013) 0.94
MutL-homolog 1 expression and risk of incident, sporadic colorectal adenoma: search for prospective biomarkers of risk for colorectal cancer. Cancer Epidemiol Biomarkers Prev (2009) 0.93
Effects of calcium and vitamin D on MLH1 and MSH2 expression in rectal mucosa of sporadic colorectal adenoma patients. Cancer Epidemiol Biomarkers Prev (2010) 0.91
The potential role of TGFbeta1, TGFbeta2 and TGFbeta3 protein expression in colorectal carcinomas. Correlation with classic histopathologic factors and patient survival. Strahlenther Onkol (2004) 0.91
The NSAID sulindac reverses rectal adenomas in colectomized patients with familial adenomatous polyposis: clinical results of a dose-finding study on rectal sulindac administration. Int J Colorectal Dis (1993) 0.90
Calcium, phosphorus, vitamin D, dairy products and colorectal carcinogenesis: a French case--control study. Br J Cancer (1996) 0.88
Vitamin D status and impact of vitamin D3 and/or calcium supplementation in a randomized pilot study in the Southeastern United States. J Am Coll Nutr (2009) 0.85
A randomized clinical trial of the effects of supplemental calcium and vitamin D3 on the APC/β-catenin pathway in the normal mucosa of colorectal adenoma patients. Cancer Prev Res (Phila) (2012) 0.85
Supplemental administration of 1 alpha-hydroxyvitamin D3 inhibits promotion by intrarectal instillation of lithocholic acid in N-methyl-N-nitrosourea-induced colonic tumorigenesis in rats. Carcinogenesis (1989) 0.83
Comparison of MIB-1 proliferation index with S-phase fraction in human breast carcinomas. Br J Cancer (1996) 0.81
Defective processing of the transforming growth factor-beta1 in azoxymethane-induced mouse colon tumors. Mol Carcinog (2003) 0.81
Paracrine action of transforming growth factor-alpha in rectal crypt epithelium of humans. Cell Biol Int (2002) 0.81
Markers of the APC/β-catenin signaling pathway as potential treatable, preneoplastic biomarkers of risk for colorectal neoplasms. Cancer Epidemiol Biomarkers Prev (2012) 0.81
Colorectal mucosal expression of MSH2 as a potential biomarker of risk for colorectal neoplasms. Cancer Epidemiol Biomarkers Prev (2009) 0.78
Effects of calcium and vitamin D3 on transforming growth factors in rectal mucosa of sporadic colorectal adenoma patients: a randomized controlled trial. Mol Carcinog (2013) 0.77
Transforming growth factors and receptor as potential modifiable pre-neoplastic biomarkers of risk for colorectal neoplasms. Mol Carcinog (2014) 0.76
Dietary goals for the United States: statement of The American Medical Association to the Select Committee on Nutrition and Human Needs, United States Senate. R I Med J (1977) 0.75